Research ReportNeonatal RU-486 (mifepristone) exposure increases androgen receptor immunoreactivity and sexual behavior in male rats

- We examined the role of PRs on the organization of sexual behavior and brain ARs.
- Neonatal RU-486 increased adult male sexual behavior and AR expression in males.
- Neonatal RU-486 did not alter sexual behavior or AR expression in females.
- The increase in AR expression may act to increase male sexual behavior.

Progesterone and progestin receptors (PRs) are known to play a role in the development of brain physiology and behavior in many different species. The distribution and regulation of PRs within the developing brain suggest that they likely contribute to the organization of the brain and behavior in a sex-specific manner. We examined the role of PR signaling during development on the organization of adult sexual behavior and androgen receptor (AR) expression in the brain. We administered the PR antagonist, RU-486, subcutaneously to male and female rats on postnatal days 1-7 (0=day of birth) and examined adult sexual behavior and AR-immunoreactivity (AR-ir) in the adult brain. A typical sex difference in lordosis quotient (LQ) was observed and neonatal RU-486 treatment did not alter this behavior. In contrast, neonatal RU-486 treatment increased adult male sexual behavior and AR-ir in several brain areas in males. These data indicate that a transient disruption in PR signaling during development can have lasting consequences on the male brain and may increase male sexual behavior in part by increasing AR expression, and therefore androgen sensitivity, in adulthood.